Social Contextual Factors Associated with Entry into Opiate Agonist Treatment Among Injection Drug Users

References

• Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, CDC, 2000; 12(1).
   Google Scholar
• Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: Cases of HIV Infection and AIDS in the United States. Vol. 14. Atlanta, GA: U.S. Department of Health and Human Services, 2002.
   Google Scholar
• Vlahov D, Junge B. The role of needle exchange programs in HIV prevention.Public Health Rep 1998; 113(suppl 1):75–80. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Spijkerman I J, van Ameijden E J, Mientjes G H, Coutinho R A, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users.J Clin Epidemiol 1996; 49(10):1149–1154. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Metzger D S, Woody G E, McLellan A T, O'Brien C P, Druley P, Navaline H, DePhilippis D, Stolley P, Abrutyn E. Human immunodeficiency virus seorconversion among intravenous drug users in-and out-of treatment: an 18 month prospective follow-up.J Acquir Immune Defic Syndr 1993; 6(9):1049–1056. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Yancovitz S R, Des Jarlais D C, Peyser N P, Drew E, Friedmann P, Trigg H L, Robinson J W. A randomized trial of an interim methadone maintenance clinic.Am J Public Health 1991; 81(9):1185–1191. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ball J C, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer Verlag, 1991.
   Google Scholar
• Institute of Medicine. Treating Drug Problems, Vol. 1: A Study of the Evolution, Effectiveness, and Financing of Public and Private Drug Treatment Systems. Washington, DC: National Academy Press, 1990.
   Google Scholar
• Camacho L M, Bartholowmew N G, Joe G W, Simpson D D. Maintenance of HIV risk reduction among injection opioid users: a 12-month post-treatment follow-up.Drug Alcohol Depend 1997; 47(1):11–18. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Watkins K E, Metzger D, Woody G, McLellan A T. High-risk sexual behaviors of intravenous drug users in-and out-of treatment: implications for the spread of HIV infection.Am J Drug Alcohol Abuse 1992; 18(4):389–398. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Friedman S R, Jose B, Deren S, Des Jarlais D, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National Aids Research Consortium.Am J Epidemiol 1995; 142(8):864–874. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moss A R, Vranizan K, Gorter R, Bacchetti P, Watters J, Osmond D. HIV seroconversion in intravenous drug users in San Francisco, 1985–1990.AIDS 1994; 8(2):223–231. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• COMPA, (New York State Committee of Methadone Program Administrators, Inc.). Regarding Methadone Treatment: A Review. Vol. 6. New York, 1997:9–10.
   Google Scholar
• Schutz C G, Rapiti E, Vlahov D, Anthony J C. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injection drug users.Alcohol Drug Depend 1994; 36(2):129–138., [CROSSREF]
   PubMed Web of Science ®Google Scholar
• American Methadone Treatment Association. 1998 Methadone Maintenance Program and Patient Census in the U.S., New York: American Association for the Treatment of Opioid Dependence, April 1999.
   Google Scholar
• Centers for Disease Control and Prevention. Risk behaviors for HIV transmission among intravenous drug users not in treatment-United States.MMWR 1990; 39(16):273–276.
   PubMedGoogle Scholar
• Schutz C G, Rapiti E, Vlahov D, Anthony J C. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injection drug users.Alcohol Drug Depend 1994; 36(2):129–138. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shah N G, Celentano D D, Vlahov D, Stambolis V, Johnson L, Nelson K E, Strathdee S A. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus.AIDS 2000; 14(13):2035–2043. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Riley E D, Safaeian M, Strathdee S A, Brooner R K, Beilenson P, Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program.Subst Use Misuse 2002; 37(14):1869–1886. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zule W A, Desmond D P. Factors predicting entry of injecting drug users into substance abuse treatment.Am J Drug Alcohol Abuse 2000; 26(2):247–261. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Booth R E, Corsi K F, Mikulich S K. Improving entry into methadone maintenance among out-of-treatment injection drug users.J Subst Abuse Treat 2003; 24(4):305–311. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Goehl L, Nunes E, Quitkin F, Hilton I. Social networks and methadone treatment outcome: the costs and benefits of social ties.Am J Drug Alcohol Abuse 1993; 19(3):251–262. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gogineni A, Stein M D, Friedmann P D. Social relationships and intravenous drug use among methadone maintenance patients.Drug Alcohol Depend 2001; 64(1):47–53. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Westreich L, Heitner C, Cooper M, Galanter M, Guedj P. Perceived social support and treatment retention on an inpatient addiction treatment unit.Am J Addict 1997; 6(2):144–149. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tuten M, Jones H E. A partner's drug-using status impacts women's drug treatment outcome.Drug Alcohol Depend 2003; 70(3):327–330. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lundgren L M, Schilling R F, Fitzgerald T, Davis K, Amodeo M. Parental status of women injection users and entry to methadone maintenance.Subst Use Misuse 2003; 38(8):1109–1131. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Appel P W, Ellison A A, Jansky H K, Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.Am J Drug Alcohol Abuse 2004; 30(1):129–153. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vlahov D, Junge B, Brookmeyer R, Cohn S, Riley E, Armenian H, Beilenson P. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program.J Acquir Immune Defic Syndr Human Retrovirol 1997; 16(5):400–406.
   PubMedGoogle Scholar
• McLellan A T, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index.J Subst Abuse Treat 1992; 9(3):199–213. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. State Methadone Treatment Guidelines. Treatment Improvement Protocol (TIP) Series, Number 1. DHHS Pub. No. (SMA) 93-1991. Washington, DC: U.S. Government Printing Office, 1993.
   Google Scholar
• Dobkin P L, De C M, Paraherakis A, Gill K. The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers.Addiction 2002; 97(3):347–356. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kline A. Pathways into drug user treatment: the influence of gender and racial/ethnic identity.Subst Use Misuse 1996; 31(3):323–342. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar